Publicaciones en colaboración con investigadores/as de University of Bordeaux (19)

2023

  1. Reuniting philosophy and science to advance cancer research

    Biological Reviews, Vol. 98, Núm. 5, pp. 1668-1686

2022

  1. How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)

    Cancer Treatment Reviews, Vol. 103

2021

  1. Gene expression profiling as a potential tool for precision oncology in non-small cell lung cancer

    Cancers, Vol. 13, Núm. 19

  2. Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer

    Trends in Cancer, Vol. 7, Núm. 5, pp. 410-429

2020

  1. Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma

    JCI Insight, Vol. 5, Núm. 15

  2. Meeting report – first discoidin domain receptors meeting

    Journal of Cell Science

  3. Squamous differentiation requires G2/mitosis slippage to avoid apoptosis

    Cell Death and Differentiation, Vol. 27, Núm. 8, pp. 2451-2467

2019

  1. Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance

    Cell Adhesion and Migration, Vol. 12, Núm. 4, pp. 394-397

  2. KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS

    Cell, Vol. 172, Núm. 4, pp. 857-868.e15

  3. Molecular determinants of acquired resistance to BRAF inhibition in human lung cancer

    Lung Cancer

2017

  1. A Braf kinase-inactive mutant induces lung adenocarcinoma

    Nature, Vol. 548, Núm. 7666, pp. 239-243

2014

  1. Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors

    Molecular and Cellular Biology, Vol. 34, Núm. 8, pp. 1452-1459

2011

  1. C-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma

    Cancer Cell, Vol. 19, Núm. 5, pp. 652-663

2010

  1. A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma

    Cancer Cell, Vol. 18, Núm. 1, pp. 63-73

2007

  1. Cdk1 is sufficient to drive the mammalian cell cycle

    Nature, Vol. 448, Núm. 7155, pp. 811-815

  2. Mice thrive without Cdk4 and Cdk2

    Molecular Oncology, Vol. 1, Núm. 1, pp. 72-83

2005

  1. Cell cycle and cancer: Genetic analysis of the role of cyclin-dependent kinases

    Cold Spring Harbor Symposia on Quantitative Biology

2004

  1. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

    Cell, Vol. 118, Núm. 4, pp. 493-504